Preferred Label : 2-Bromoergocryptine Mesylate;

UMLS semantic type : T109 - Organic Chemical; T121 - Pharmacologic Substance;

CAS number : 22260-51-1; FFP983J3OD;

Is substance : O;

UNII : FFP983J3OD;

InChIKey : NOJMTMIRQRDZMT-GSPXQYRGSA-N;

Details


Main resources

You can consult :


http://www.has-sante.fr/portail/display.jsp?id=c_538031
http://www.has-sante.fr/portail/jcms/c_1615038/fr/parlodel
http://www.has-sante.fr/portail/jcms/c_1615037/fr/parlodel-29052013-avis-ct10946
2013
France
French
2-Bromoergocryptine Mesylate
hyperprolactinemia
parkinson disease
bromocriptine
administration, oral
lactation
antiparkinson agents
dopamine agonists
hormone antagonists
prolactin
weaning
bromocriptine
bromocriptine
insurance, health, reimbursement
evaluation of the transparency committee
prolactinoma

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67505668
http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=67505668&typedoc=R&ref=R0167202.htm
http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=67505668&typedoc=N&ref=N0167202.htm
2010
France
French
summary of product characteristics
package leaflet
bromocriptine
parkinson disease
drug therapy, combination
drug interactions
pregnancy
capsules
administration, oral
bromocriptine
bromocriptine
dopamine agonists
dopamine agonists
antiparkinson agents
antiparkinson agents
2-Bromoergocryptine Mesylate
2-Bromoergocryptine Mesylate

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62504128
http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=62504128&typedoc=N&ref=N0167204.htm
http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=62504128&typedoc=R&ref=R0167204.htm
2010
France
French
tablets
lactation
administration, oral
prolactin
hormone antagonists
hormone antagonists
bromocriptine
bromocriptine
bromocriptine
weaning
drug interactions
2-Bromoergocryptine Mesylate
2-Bromoergocryptine Mesylate
summary of product characteristics
package leaflet

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.